動態

• 

  Mary Grace N. Tamio   shared news

  在 January 31 2024 at 08:43 PM 已編輯 public

  Unlocking the ‘ova’-coming power: immunotherapy’s role in shaping the future of ovarian cancer treatment
  
  #immunotherapy #cancer #ovariancancer #journals #articles
  
  More info | ⬇️

  

  Unlocking the ‘ova’-coming power: immunotherapy’s role in shaping the future of ovarian cancer treatment

  Ovarian cancer is a prominent cancer worldwide with a relatively low survival rate for women diagnosed. Many individuals a...
  0 0 0 0 0 0 0

  comment 留言

  thumb_upLike

  share 分享
• 

  Mary Grace N. Tamio   shared news

  在 January 14 2024 at 09:15 PM 已編輯 public

  MARCH5-mediated downregulation of ACC2 promotes fatty acid oxidation and tumor progression in ovarian cancer
  
  #acidoxidation #tumor #ovariancancer #journals #articles
  
  More info | ⬇️

  

  MARCH5-mediated downregulation of ACC2 promotes fatty acid oxidation and tumor progression in ovarian cancer

  Alterations in metabolism have been defied as hallmarks of human cancers. One of the most well-studied metabolic change in...
  0 0 0 0 0 0 0

  comment 留言

  thumb_upLike

  share 分享
• 

  Mary Grace N. Tamio   shared news

  在 January 11 2024 at 10:23 PM 已編輯 public

  Integrated immunogenomic analyses of high-grade serous ovarian cancer reveal vulnerability to combination immunotherapy
  
  #ovariancancer #immunotherapy #journals #articles
  
  More info | ⬇️

  

  Integrated immunogenomic analyses of high-grade serous ovarian cancer reveal vulnerability to combination immunotherapy

  medRxiv - The Preprint Server for Health Sciences
  0 0 0 0 0 0 0

  comment 留言

  thumb_upLike

  share 分享
• 

  Mary Grace N. Tamio   shared news

  在 December 14 2023 at 07:02 PM 已編輯 public

  Relationship between frailty and nutrition: Refining predictors of mortality after primary cytoreductive surgery for ovarian cancer
  
  #cytoreductivesurgery #ovariancancer #journals #articles
  
  More info | ⬇️

  

  Relationship between frailty and nutrition: Refining predictors of mortality after primary cytoreductive surgery for ovarian cancer

  The combination of cytoreductive surgery when it can safely be performed to residual disease <1 cm followed by platinum...
  0 0 0 0 0 0 0

  comment 留言

  thumb_upLike

  share 分享
• 

  Mary Grace N. Tamio   shared news

  在 August 08 2023 at 04:54 PM 已編輯 public

  Anti-VEGF therapy selects for clones resistant to glucose starvation in ovarian cancer xenografts
  
  #antiVEGFtherapy #glucosestarvation #ovariancancer
  
  More info | ⬇️

  

  Anti-VEGF therapy selects for clones resistant to glucose starvation in ovarian cancer xenografts

  Genetic and metabolic heterogeneity are well-known features of cancer and tumors can be viewed as an evolving mix of subcl...
  0 0 0 0 0 0 0

  comment 留言

  thumb_upLike

  share 分享